Brett Bolhofner, MD
Orthopaedic Surgery · St Petersburg, FLNPI 1134193667
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,975,834 of the $2,976,051 with a category attached, or 100.0%. Depuy Synthes Products, Inc. accounts for 100.0% of it on its own, with 5 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $90,183 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$3M
- Smith+Nephew$142
- ERMI LLC$22
- Fidia Pharma USA Inc.$19
- Bioventus LLC$17
- Abbott$17
Across 6 payments — averaging $7108.50 each. An ownership or investment interest held by the physician or an immediate family member.
- Nanohive Medical LLC$43K
What the payments were for
- Royalty or licence$2,975,834100%
- Food & beverage$2170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 28 | $2,975,834 |
| Smith+Nephew | 1 | $142 |
| ERMI LLC | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LCP$1,980,220
- LCP PLATES & SCREWS$995,614
- REAL INTELLIGENCE$142
- Journey II$142
How this compares
$2,976,051 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 80 | $573 |
| Oxycodone Hcl | 92 | $507 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $486 |
| Tramadol Hcl | 112 | $303 |
| Doxycycline Hyclate | 21 | $207 |
| Cephalexin | 25 | $145 |
| Meloxicam | 38 | $132 |
| Dexamethasone | 15 | $90 |
| Amoxicillin | 35 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in St Petersburg
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.